A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like digitalis. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-exchanging ATPase.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Amiodarone | The serum concentration of Ouabain can be increased when it is combined with Amiodarone. |
| Amphotericin B | The risk or severity of adverse effects can be increased when Amphotericin B is combined with Ouabain. |
| Clonidine | Clonidine may increase the atrioventricular blocking (AV block) activities of Ouabain. |
| Edrophonium | Edrophonium may increase the atrioventricular blocking (AV block) and arrhythmogenic activities of Ouabain. |
| Itraconazole | The serum concentration of Ouabain can be increased when it is combined with Itraconazole. |
| Kaolin | The serum concentration of Ouabain can be decreased when it is combined with Kaolin. |
| Midodrine | Ouabain may increase the bradycardic, atrioventricular blocking (AV block), and arrhythmogenic activities of Midodrine. |
| Propafenone | The serum concentration of Ouabain can be increased when it is combined with Propafenone. |
| Quinine | The serum concentration of Ouabain can be increased when it is combined with Quinine. |
| Quinidine | The serum concentration of Ouabain can be increased when it is combined with Quinidine. |
| Reserpine | The risk or severity of adverse effects can be increased when Reserpine is combined with Ouabain. |
| Telmisartan | The serum concentration of Ouabain can be increased when it is combined with Telmisartan. |
| Succinic acid | The excretion of Succinic acid can be decreased when combined with Ouabain. |
| Citrulline | The excretion of Citrulline can be decreased when combined with Ouabain. |
| Pravastatin | The excretion of Pravastatin can be decreased when combined with Ouabain. |
| Oseltamivir | The excretion of Oseltamivir can be decreased when combined with Ouabain. |
| Cefotiam | The excretion of Cefotiam can be decreased when combined with Ouabain. |
| Conjugated estrogens | The excretion of Conjugated estrogens can be decreased when combined with Ouabain. |
| Tenofovir disoproxil | The excretion of Tenofovir disoproxil can be decreased when combined with Ouabain. |
| Piperacillin | The excretion of Piperacillin can be decreased when combined with Ouabain. |
| Indomethacin | The excretion of Indomethacin can be decreased when combined with Ouabain. |
| Aminohippuric acid | The excretion of Aminohippuric acid can be decreased when combined with Ouabain. |
| Trifluridine | The excretion of Trifluridine can be decreased when combined with Ouabain. |
| Allopurinol | The excretion of Allopurinol can be decreased when combined with Ouabain. |
| Zidovudine | The excretion of Zidovudine can be decreased when combined with Ouabain. |
| Cimetidine | The excretion of Cimetidine can be decreased when combined with Ouabain. |
| Cefdinir | The excretion of Cefdinir can be decreased when combined with Ouabain. |
| Methotrexate | The excretion of Methotrexate can be decreased when combined with Ouabain. |
| Cephalexin | The excretion of Cephalexin can be decreased when combined with Ouabain. |
| Valaciclovir | The excretion of Valaciclovir can be decreased when combined with Ouabain. |
| Levocarnitine | The excretion of Levocarnitine can be decreased when combined with Ouabain. |
| Leucovorin | The excretion of Leucovorin can be decreased when combined with Ouabain. |
| Fluorescein | The excretion of Fluorescein can be decreased when combined with Ouabain. |
| Hydrocortisone | The excretion of Hydrocortisone can be decreased when combined with Ouabain. |
| Tetracycline | The excretion of Tetracycline can be decreased when combined with Ouabain. |
| Estradiol | The excretion of Estradiol can be decreased when combined with Ouabain. |
| Acyclovir | The excretion of Acyclovir can be decreased when combined with Ouabain. |
| Cefaclor | The excretion of Cefaclor can be decreased when combined with Ouabain. |
| Ranitidine | The excretion of Ranitidine can be decreased when combined with Ouabain. |
| Quinapril | The excretion of Quinapril can be decreased when combined with Ouabain. |
| Dinoprostone | The excretion of Dinoprostone can be decreased when combined with Ouabain. |
| Famotidine | The excretion of Famotidine can be decreased when combined with Ouabain. |
| Fexofenadine | The excretion of Fexofenadine can be decreased when combined with Ouabain. |
| Benzylpenicillin | The excretion of Benzylpenicillin can be decreased when combined with Ouabain. |
| Rosuvastatin | The excretion of Rosuvastatin can be decreased when combined with Ouabain. |
| Captopril | The excretion of Captopril can be decreased when combined with Ouabain. |
| Sitagliptin | The excretion of Sitagliptin can be decreased when combined with Ouabain. |
| Cefazolin | The excretion of Cefazolin can be decreased when combined with Ouabain. |
| Ceftizoxime | The excretion of Ceftizoxime can be decreased when combined with Ouabain. |
| Cefacetrile | The excretion of Cefacetrile can be decreased when combined with Ouabain. |
| Ceftibuten | The excretion of Ceftibuten can be decreased when combined with Ouabain. |
| Tazobactam | The excretion of Tazobactam can be decreased when combined with Ouabain. |
| Cyclic adenosine monophosphate | The excretion of Cyclic adenosine monophosphate can be decreased when combined with Ouabain. |
| Cholic Acid | The excretion of Cholic Acid can be decreased when combined with Ouabain. |
| Glutaric Acid | The excretion of Glutaric Acid can be decreased when combined with Ouabain. |
| Oxalic Acid | The excretion of Oxalic Acid can be decreased when combined with Ouabain. |
| Taurocholic acid | The excretion of Taurocholic acid can be decreased when combined with Ouabain. |
| Doripenem | The excretion of Doripenem can be decreased when combined with Ouabain. |
| Saxagliptin | The excretion of Saxagliptin can be decreased when combined with Ouabain. |
| Ellagic acid | The excretion of Ellagic acid can be decreased when combined with Ouabain. |
| Cefaloridine | The excretion of Cefaloridine can be decreased when combined with Ouabain. |
| Avibactam | The excretion of Avibactam can be decreased when combined with Ouabain. |
| Silibinin | The excretion of Silibinin can be decreased when combined with Ouabain. |
| Tenofovir alafenamide | The excretion of Tenofovir alafenamide can be decreased when combined with Ouabain. |
| Baricitinib | The serum concentration of Baricitinib can be increased when it is combined with Ouabain. |
| Relebactam | The excretion of Relebactam can be decreased when combined with Ouabain. |
| Tenofovir | The excretion of Tenofovir can be decreased when combined with Ouabain. |
| Dexamethasone | The excretion of Dexamethasone can be decreased when combined with Ouabain. |
| Oxytetracycline | The excretion of Oxytetracycline can be decreased when combined with Ouabain. |
| Prednisolone phosphate | The excretion of Prednisolone phosphate can be decreased when combined with Ouabain. |
| Dexamethasone acetate | The excretion of Dexamethasone acetate can be decreased when combined with Ouabain. |
| Tolevamer | The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Ouabain. |
| Sulpiride | The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Ouabain. |
| Parathyroid hormone | The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Ouabain. |
| Eluxadoline | The serum concentration of Eluxadoline can be increased when it is combined with Ouabain. |
| Calcitriol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Calcitriol is combined with Ouabain. |
| Calcifediol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Calcifediol is combined with Ouabain. |
| Ergocalciferol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Ergocalciferol is combined with Ouabain. |
| Cholecalciferol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Cholecalciferol is combined with Ouabain. |
| Paricalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Ouabain. |
| Dihydrotachysterol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Dihydrotachysterol is combined with Ouabain. |
| Alfacalcidol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Alfacalcidol is combined with Ouabain. |
| Seocalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Seocalcitol is combined with Ouabain. |
| Inecalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Inecalcitol is combined with Ouabain. |
| Becocalcidiol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Becocalcidiol is combined with Ouabain. |
| Eldecalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Eldecalcitol is combined with Ouabain. |
| 1alpha,24S-Dihydroxyvitamin D2 | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when 1alpha,24S-Dihydroxyvitamin D2 is combined with Ouabain. |
| Elocalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Elocalcitol is combined with Ouabain. |
| Maxacalcitol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Maxacalcitol is combined with Ouabain. |
| Doxercalciferol | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Doxercalciferol is combined with Ouabain. |
| Vitamin D | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Vitamin D is combined with Ouabain. |
| 1alpha-Hydroxyvitamin D5 | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when 1alpha-Hydroxyvitamin D5 is combined with Ouabain. |
| Previtamin D(3) | The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Previtamin D(3) is combined with Ouabain. |
| Esmolol | Esmolol may increase the bradycardic activities of Ouabain. |
| Betaxolol | Betaxolol may increase the bradycardic activities of Ouabain. |
| Metoprolol | Metoprolol may increase the bradycardic activities of Ouabain. |
| Atenolol | Atenolol may increase the bradycardic activities of Ouabain. |
| Timolol | Timolol may increase the bradycardic activities of Ouabain. |
| Sotalol | Sotalol may increase the bradycardic activities of Ouabain. |
| Propranolol | Propranolol may increase the bradycardic activities of Ouabain. |